News Center


Somatic RNA variant calling in solid tumors

About Gene fusions are the latest type of biomarker to receive broad applicability in cancer management. More than 10,000 gene fusions have already been identified in human cancers and it is estimated that up to 80% of solid tumors could benefit from gene fusion...

Read More


Summer 2022 Newsletter

Attend/Stream the EventOur first-ever Investor Day is on September 20th in NYC! We'll be streaming live as our execs discuss the latest news and innovations in our journey to...

Read More


The Launch of SOPHiA DDM™ Dispatch

SOPHiA GENETICS is excited to announce the launch of SOPHiA DDM™ Dispatch, a new way for our SOPHiA GENETICS Integrated Access partner labs to work with their clients. SOPHiA DDM™ Dispatch make its it easier to work with clients directly and control logistics within your lab.

Read More

pink dots icon

Want to know more?
Get in touch with us.

Our client services team is on hand to help.